{"transactions":[{"id":784729,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-11T20:05:10.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":696,"price":45.31,"value":31535.76,"ownership":{"direct":true},"balance_after":27712,"source":{"system":"sec-edgar","filing":"0001104659-26-058634","document":"tm2614263-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465926058634/tm2614263-1_4seq1.xml","form_type":"4"}},{"id":793814,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T22:19:15.000Z","date":"2026-04-30","kind":"grant","planned":true,"acquired":true,"shares":3562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":28408,"source":{"system":"sec-edgar","filing":"0001104659-26-055058","document":"tm2613528-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465926055058/tm2613528-2_4seq1.xml","form_type":"4"}},{"id":980197,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-04T21:05:12.000Z","date":"2025-12-02","kind":"sale","planned":true,"acquired":false,"shares":1200,"price":139,"value":166800.0,"ownership":{"direct":true},"balance_after":24846,"source":{"system":"sec-edgar","filing":"0001104659-25-118455","document":"tm2532785-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925118455/tm2532785-1_4seq1.xml","form_type":"4"}},{"id":985037,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:56:40.000Z","date":"2025-11-28","kind":"sale","planned":true,"acquired":false,"shares":2000,"price":127.48,"value":254960.0,"ownership":{"direct":true},"balance_after":26046,"source":{"system":"sec-edgar","filing":"0001104659-25-117422","document":"tm2532514-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925117422/tm2532514-1_4seq1.xml","form_type":"4"}},{"id":1119579,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T22:06:02.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":13296,"derivative":{"exercise_price":16,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-25-057436","document":"tm2517412-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925057436/tm2517412-1_4seq1.xml","form_type":"4"}},{"id":1119578,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T22:06:02.000Z","date":"2025-06-04","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":16,"value":64000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":28046,"source":{"system":"sec-edgar","filing":"0001104659-25-057436","document":"tm2517412-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925057436/tm2517412-1_4seq1.xml","form_type":"4"}},{"id":1159160,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T23:31:25.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":360,"price":160,"value":57600.0,"ownership":{"direct":true},"balance_after":24046,"source":{"system":"sec-edgar","filing":"0001104659-25-044673","document":"tm2514079-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925044673/tm2514079-7_4seq1.xml","form_type":"4"}},{"id":1159159,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T23:31:25.000Z","date":"2025-05-01","kind":"grant","planned":true,"acquired":true,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":24406,"source":{"system":"sec-edgar","filing":"0001104659-25-044673","document":"tm2514079-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925044673/tm2514079-7_4seq1.xml","form_type":"4"}},{"id":1179422,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"mcCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T20:30:33.000Z","date":"2025-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":46035,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated February 6, 2025, by and among the Issuer, Globus Medical, Inc. (\"Globus\") and Palmer Merger Sub, Inc., a direct, wholly owned subsidiary of Globus (\"Merger Sub\"), Merger Sub merged with and into the Issuer, and the Issuer became a wholly owned subsidiary of Globus upon consummation of the merger (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, (i) each outstanding share of Common Stock was automatically converted into the right to receive $5.85 in cash (the \"Merger Consideration\"), (ii) each outstanding award of restricted stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award and (b) the Merger Consideration, and (iii) each outstanding award of performance stock units automatically converted into the right to receive, without interest and subject to withholding taxes, the product of (a) the aggregate number of Common Stock underlying such award, assuming that the applicable performance goals have been achieved at the greater of target and actual level of performance as determined by the compensation committee, and (b) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-050474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000095017025050474/ownership.xml","form_type":"4"}},{"id":1409749,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-11T21:02:28.000Z","date":"2024-09-09","kind":"sale","planned":true,"acquired":false,"shares":800,"price":220,"value":176000.0,"ownership":{"direct":true},"balance_after":23140,"source":{"system":"sec-edgar","filing":"0001104659-24-098967","document":"tm2423831-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924098967/tm2423831-2_4seq1.xml","form_type":"4"}},{"id":1432502,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-15T20:19:44.000Z","date":"2024-08-14","kind":"exercise","planned":false,"acquired":false,"shares":7518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.94,"expiration_date":"2027-04-01","underlying":"Common Stock","underlying_shares":7518},"source":{"system":"sec-edgar","filing":"0001104659-24-090124","document":"tm2421806-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924090124/tm2421806-1_4seq1.xml","form_type":"4"}},{"id":1432501,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-15T20:19:44.000Z","date":"2024-08-14","kind":"exercise","planned":false,"acquired":false,"shares":1019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.94,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":1019},"source":{"system":"sec-edgar","filing":"0001104659-24-090124","document":"tm2421806-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924090124/tm2421806-1_4seq1.xml","form_type":"4"}},{"id":1432500,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-15T20:19:44.000Z","date":"2024-08-14","kind":"exercise","planned":false,"acquired":true,"shares":8537,"price":0.94,"value":8024.78,"ownership":{"direct":true},"balance_after":23940,"source":{"system":"sec-edgar","filing":"0001104659-24-090124","document":"tm2421806-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924090124/tm2421806-1_4seq1.xml","form_type":"4"}},{"id":1500304,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-28T22:56:27.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":19169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 23, 2024 or (ii) the next Annual Meeting following May 23, 2024, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 19,169 RSUs."}],"balance_after":46035,"source":{"system":"sec-edgar","filing":"0001610717-24-000265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000161071724000265/form4.xml","form_type":"4"}},{"id":1519061,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:30:20.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":1019,"derivative":{"exercise_price":0.94,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001104659-24-060582","document":"tm2414211-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924060582/tm2414211-1_4seq1.xml","form_type":"4"}},{"id":1519060,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-13T20:30:20.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0.94,"value":2350.0,"ownership":{"direct":true},"balance_after":15403,"source":{"system":"sec-edgar","filing":"0001104659-24-060582","document":"tm2414211-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924060582/tm2414211-1_4seq1.xml","form_type":"4"}},{"id":1526318,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T22:05:36.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":12903,"source":{"system":"sec-edgar","filing":"0001104659-24-057563","document":"tm2413647-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924057563/tm2413647-1_4seq1.xml","form_type":"4"}},{"id":1860422,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-09T20:37:10.000Z","date":"2023-06-07","kind":"purchase","planned":false,"acquired":true,"shares":7500,"price":22.8844,"value":171633.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $22.8500 to $22.8896, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,754 restricted stock units."}],"balance_after":26866,"source":{"system":"sec-edgar","filing":"0001610717-23-000108","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000161071723000108/form4.xml","form_type":"4"}},{"id":1874742,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-30T21:16:37.000Z","date":"2023-05-25","kind":"grant","planned":false,"acquired":true,"shares":6754,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2023 or (ii) the next Annual Meeting following May 25, 2023, subject to the Reporting Person's continued service to the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 6,754 RSUs."}],"balance_after":19366,"source":{"system":"sec-edgar","filing":"0001610717-23-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000161071723000075/form4.xml","form_type":"4"}},{"id":1910129,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-01T23:48:30.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":12187,"source":{"system":"sec-edgar","filing":"0001104659-23-054646","document":"tm2314266-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923054646/tm2314266-4_4seq1.xml","form_type":"4"}},{"id":1943056,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-21T20:05:35.000Z","date":"2023-03-17","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of options originally reported in the Reporting Person's Form 3 dated May 2, 2018 understated the number of shares of common stock underlying the option by one share."}],"balance_after":3519,"derivative":{"exercise_price":0.94,"expiration_date":"2027-01-01","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001104659-23-035049","document":"tm2310036-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923035049/tm2310036-1_4seq1.xml","form_type":"4"}},{"id":1943055,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T20:05:35.000Z","date":"2023-03-17","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":0.94,"value":3760.0,"ownership":{"direct":true},"balance_after":11518,"source":{"system":"sec-edgar","filing":"0001104659-23-035049","document":"tm2310036-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923035049/tm2310036-1_4seq1.xml","form_type":"4"}},{"id":2253305,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-28T01:12:13.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":4155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 26, 2022 or (ii) the next Annual Meeting following May 26, 2022, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,155 RSUs."}],"balance_after":12612,"source":{"system":"sec-edgar","filing":"0001567619-22-011892","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761922011892/doc1.xml","form_type":"4"}},{"id":2253304,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-28T01:01:41.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":4155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 26, 2022 or (ii) the next Annual Meeting following May 26, 2022, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,155 RSUs."}],"balance_after":12612,"source":{"system":"sec-edgar","filing":"0001567619-22-011889","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761922011889/doc1.xml","form_type":"4"}},{"id":2276167,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-11T00:46:14.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":1243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on April 28, 2023, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":1243,"derivative":{"exercise_price":211.29,"expiration_date":"2032-04-28","underlying":"Common Stock","underlying_shares":1243},"source":{"system":"sec-edgar","filing":"0001104659-22-058414","document":"tm2215111-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465922058414/tm2215111-2_4seq1.xml","form_type":"4"}},{"id":2695030,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T00:58:16.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":1167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2021 or (ii) the next Annual Meeting following May 25, 2021, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,167 RSUs."}],"balance_after":8457,"source":{"system":"sec-edgar","filing":"0001567619-21-011219","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761921011219/doc1.xml","form_type":"4"}},{"id":2695029,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-27T00:58:16.000Z","date":"2021-05-24","kind":"sale","acquired":false,"shares":482,"price":149.65,"value":72131.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":7290,"source":{"system":"sec-edgar","filing":"0001567619-21-011219","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761921011219/doc1.xml","form_type":"4"}},{"id":2732995,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-03T21:20:12.000Z","date":"2021-04-29","kind":"grant","acquired":true,"shares":1175,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on April 29, 2022, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":1175,"derivative":{"exercise_price":240.68,"expiration_date":"2031-04-29","underlying":"Common Stock","underlying_shares":1175},"source":{"system":"sec-edgar","filing":"0001104659-21-060326","document":"tm2114992-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465921060326/tm2114992-7_4seq1.xml","form_type":"4"}},{"id":3135077,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T18:31:47.000Z","date":"2020-05-21","kind":"sale","acquired":false,"shares":1020,"price":126.5,"value":129030.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,376 restricted stock units."}],"balance_after":7772,"source":{"system":"sec-edgar","filing":"0001567619-20-011147","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761920011147/doc1.xml","form_type":"4"}},{"id":3135076,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T18:31:47.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":1376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 21, 2020 or (ii) the next Annual Meeting following May 21, 2020, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,376 restricted stock units."}],"balance_after":8792,"source":{"system":"sec-edgar","filing":"0001567619-20-011147","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761920011147/doc1.xml","form_type":"4"}},{"id":3163656,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-05T00:39:26.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":3501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on April 30, 2021, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":3501,"derivative":{"exercise_price":71.66,"expiration_date":"2030-04-30","underlying":"Common Stock","underlying_shares":3501},"source":{"system":"sec-edgar","filing":"0001104659-20-056421","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465920056421/a4.xml","form_type":"4"}},{"id":3267854,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-18T16:35:56.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":4218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest ratably on a monthly basis and become fully vested on February 13, 2021, the 12-month anniversary of the grant date."}],"balance_after":4218,"derivative":{"exercise_price":39.58,"expiration_date":"2027-02-13","underlying":"Common Stock","underlying_shares":4218},"source":{"system":"sec-edgar","filing":"0001209191-20-010161","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120010161/doc4.xml","form_type":"4"}},{"id":3267853,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-18T16:35:56.000Z","date":"2020-02-13","kind":"grant","acquired":true,"shares":1452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount beneficially owned includes 6,788 restricted stock units (RSUs) that vest on service-based vesting dates and 2,422 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":9210,"source":{"system":"sec-edgar","filing":"0001209191-20-010161","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919120010161/doc4.xml","form_type":"4"}},{"id":3372813,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T00:23:04.000Z","date":"2019-11-11","kind":"sale","acquired":false,"shares":800,"price":104.35,"value":83480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,913 restricted stock units."}],"balance_after":7416,"source":{"system":"sec-edgar","filing":"0001567619-19-021256","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761919021256/doc1.xml","form_type":"4"}},{"id":3515165,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-22T21:57:56.000Z","date":"2019-05-20","kind":"grant","acquired":true,"shares":2913,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 20, 2019 or (ii) the next Annual Meeting following May 20, 2019, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,913 RSUs."}],"balance_after":8216,"source":{"system":"sec-edgar","filing":"0001567619-19-011866","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000156761919011866/doc1.xml","form_type":"4"}},{"id":3538067,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-06T22:01:49.000Z","date":"2019-05-02","kind":"grant","acquired":true,"shares":4569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on May 2, 2020, subject to the Reporting Person's continuous service to the Issuer through such date."}],"balance_after":4569,"derivative":{"exercise_price":49.96,"expiration_date":"2029-05-02","underlying":"Common Stock","underlying_shares":4569},"source":{"system":"sec-edgar","filing":"0001104659-19-027217","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465919027217/a4.xml","form_type":"4"}},{"id":3654664,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-15T18:38:43.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":2605,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options vest ratably on a monthly basis and become fully vested on February 13, 2020, the 12-month anniversary of the grant date."}],"balance_after":2605,"derivative":{"exercise_price":55.24,"expiration_date":"2026-02-13","underlying":"Common Stock","underlying_shares":2605},"source":{"system":"sec-edgar","filing":"0001209191-19-010779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119010779/doc4.xml","form_type":"4"}},{"id":3654663,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-15T18:38:43.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount beneficially owned includes 5,336 restricted stock units (RSUs) that vest on service-based vesting dates and 2,422 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":7758,"source":{"system":"sec-edgar","filing":"0001209191-19-010779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119010779/doc4.xml","form_type":"4"}},{"id":3710579,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-03T16:25:22.000Z","date":"2018-12-31","kind":"grant","acquired":true,"shares":133,"price":47.26,"value":6285.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person elected to receive vested deferred stock units (DSUs) in lieu of quarterly cash retainer payments. The DSUs are settled in shares of the issuer's common stock as described below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount beneficially owned includes 4,477 restricted stock units (RSUs) that vest on service-based vesting dates and 2,422 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":6899,"source":{"system":"sec-edgar","filing":"0001209191-19-000948","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919119000948/doc4.xml","form_type":"4"}},{"id":3802800,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-02T16:35:14.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":84,"price":74.65,"value":6270.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person elected to receive vested deferred stock units (DSUs) in lieu of quarterly cash retainer payments. The DSUs are settled in shares of the issuer's common stock as described below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount beneficially owned includes 4,477 restricted stock units (RSUs) that vest on service-based vesting dates and 2,289 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":6766,"source":{"system":"sec-edgar","filing":"0001209191-18-053183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118053183/doc4.xml","form_type":"4"}},{"id":3876622,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T09:39:04.000Z","date":"2018-06-30","kind":"grant","acquired":true,"shares":114,"price":55.2,"value":6292.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person elected to receive vested deferred stock units (DSUs) in lieu of quarterly cash retainer payments. The DSUs are settled in shares of the issuer's common stock as described below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount beneficially owned includes 4,477 restricted stock units (RSUs) that vest on service-based vesting dates and 2,205 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":6682,"source":{"system":"sec-edgar","filing":"0001209191-18-040554","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118040554/doc4.xml","form_type":"4"}},{"id":3920434,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-23T23:18:03.000Z","date":"2018-05-21","kind":"grant","acquired":true,"shares":3785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 21, 2018 or (ii) the next Annual Meeting following May 21, 2018, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,785 RSUs."}],"balance_after":5303,"source":{"system":"sec-edgar","filing":"0001140361-18-025423","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000114036118025423/doc1.xml","form_type":"4"}},{"id":3941033,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-05-10T01:19:41.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":17296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable on May 2, 2019, subject to the Reporting Person's continuous service to the Issuer through such date.  The option was erroneously included on the Reporting Person's Form 3 filed on May 2, 2018."}],"balance_after":17296,"derivative":{"exercise_price":16,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":17296},"source":{"system":"sec-edgar","filing":"0001104659-18-031865","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031865/a4.xml","form_type":"4"}},{"id":3941032,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:19:41.000Z","date":"2018-05-07","kind":"purchase","acquired":true,"shares":3000,"price":16,"value":48000.0,"ownership":{"direct":false,"nature":"By trust"},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001104659-18-031865","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031865/a4.xml","form_type":"4"}},{"id":3974573,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-03T16:58:00.000Z","date":"2018-03-30","kind":"grant","acquired":true,"shares":165,"price":38.05,"value":6278.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount beneficially owned includes 4,477 restricted stock units (RSUs) that vest on service-based vesting dates and 2,091 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":6568,"source":{"system":"sec-edgar","filing":"0001209191-18-023110","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118023110/doc4.xml","form_type":"4"}},{"id":4023776,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T19:52:22.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":10.62,"value":53100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option, which provided for vesting in full on the earlier of June 13, 2018 and the date of the annual stockholder meeting following June 13, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-18-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000123580218000024/primary_doc.xml","form_type":"4"}},{"id":4023775,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T19:52:22.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":5.74,"value":57400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option, which provided for vesting in full on the earlier of June 14, 2017 and the date of the annual stockholder meeting following June 14, 2016, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":18.26,"expiration_date":"2026-06-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001235802-18-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000123580218000024/primary_doc.xml","form_type":"4"}},{"id":4023774,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-01T19:52:22.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":15000,"price":12.64,"value":189600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting in quarterly installments over 36 months commencing on December 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option."}],"balance_after":0,"derivative":{"exercise_price":11.36,"expiration_date":"2024-11-09","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001235802-18-000024","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000123580218000024/primary_doc.xml","form_type":"4"}},{"id":4023773,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2018-03-01T19:52:22.000Z","date":"2018-02-28","kind":"disposition_to_issuer","acquired":false,"shares":5441,"price":24,"value":130584.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235802-18-000024","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000123580218000024/primary_doc.xml","form_type":"4"}},{"id":4041700,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-22T16:57:41.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":5275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vests in full on February 20, 2019."}],"balance_after":5275,"derivative":{"exercise_price":27.3,"expiration_date":"2025-02-20","underlying":"Common Stock","underlying_shares":5275},"source":{"system":"sec-edgar","filing":"0001209191-18-012497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118012497/doc4.xml","form_type":"4"}},{"id":4041699,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-22T16:57:41.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":1739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount beneficially owned includes 4,477 restricted stock units (RSUs) that vest on service-based vesting dates and 1,926 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":6403,"source":{"system":"sec-edgar","filing":"0001209191-18-012497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919118012497/doc4.xml","form_type":"4"}},{"id":4282211,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T20:26:16.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the earlier to occur of June 13, 2018 and the date of the Company's annual meeting of stockholders immediately following June 13, 2017, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":5000,"derivative":{"exercise_price":13.38,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-17-000082","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000123580217000082/primary_doc.xml","form_type":"4"}},{"id":4282210,"issuer":{"id":16119,"kind":"organization","name":"ENTELLUS MEDICAL INC","symbol":"ENTL"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.001 par value","published_at":"2017-06-14T20:26:16.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,500 shares that will be issued over time upon vesting pursuant to a restricted stock unit granted under the Entellus Medical, Inc. 2015 Incentive Award Plan."}],"balance_after":5441,"source":{"system":"sec-edgar","filing":"0001235802-17-000082","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000123580217000082/primary_doc.xml","form_type":"4"}},{"id":4301214,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-30T22:54:29.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":3545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the shares subject to the option vest on each monthly anniversary measured from May 25, 2017 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the issuer."}],"balance_after":3545,"derivative":{"exercise_price":74.07,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":3545},"source":{"system":"sec-edgar","filing":"0001140361-17-022923","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000114036117022923/doc1.xml","form_type":"4"}},{"id":4301213,"issuer":{"id":12422,"kind":"organization","name":"NEVRO CORP","symbol":"NVRO"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T22:54:29.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":1518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the one year anniversary of May 25, 2017, subject to the Reporting Person's continued service to the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,518 RSUs."}],"balance_after":1518,"source":{"system":"sec-edgar","filing":"0001140361-17-022923","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1454092/000114036117022923/doc1.xml","form_type":"4"}},{"id":4443623,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-16T16:52:10.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":3932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vests in full on February 14, 2018."}],"balance_after":3932,"derivative":{"exercise_price":23.95,"expiration_date":"2024-02-14","underlying":"Common Stock","underlying_shares":3932},"source":{"system":"sec-edgar","filing":"0001209191-17-011516","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919117011516/doc4.xml","form_type":"4"}},{"id":4443622,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-16T16:52:10.000Z","date":"2017-02-14","kind":"grant","acquired":true,"shares":1252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The amount beneficially owned includes 2,738 restricted stock units (RSUs) that vest on service-based vesting dates and 1,926 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":4664,"source":{"system":"sec-edgar","filing":"0001209191-17-011516","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919117011516/doc4.xml","form_type":"4"}},{"id":4504588,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T17:16:13.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":447,"price":25.4,"value":11353.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person elected to receive vested deferred stock units (DSUs) in lieu of quarterly cash retainer payments. The DSUs are settled in shares of the issuer's common stock as described below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount beneficially owned includes 1,486 restricted stock units (RSUs) that vest on service-based vesting dates and 1,926 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends."}],"balance_after":3412,"source":{"system":"sec-edgar","filing":"0001209191-17-001183","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919117001183/doc4.xml","form_type":"4"}},{"id":4588198,"issuer":{"id":72915,"kind":"organization","name":"SURMODICS INC","symbol":"SRDX"},"owners":[{"id":48325,"kind":"person","name":"mcCormick Shawn","position":1,"cik":"0001454092","reported_name":"McCormick Shawn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-04T16:50:09.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":378,"price":30.09,"value":11374.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person elected to receive vested deferred stock units (DSUs) in lieu of quarterly cash retainer payments. The DSUs are settled in shares of the issuer's common stock as described below."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount beneficially owned includes 1,486 restricted stock units (RSUs) that vest on service-based vesting dates and 1,479 deferred stock units (DSUs) that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting persons' service as a director ends."}],"balance_after":2965,"source":{"system":"sec-edgar","filing":"0001209191-16-144370","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/924717/000120919116144370/doc4.xml","form_type":"4"}}]}